These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38149244)

  • 1. Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers.
    Najjary S; de Koning W; Kros JM; Mustafa DAM
    Front Immunol; 2023; 14():1305644. PubMed ID: 38149244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
    Najjary S; Kros JM; de Koning W; Vadgama D; Lila K; Wolf J; Mustafa DAM
    Acta Neuropathol Commun; 2023 Apr; 11(1):64. PubMed ID: 37061716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the expression of cell interaction-related pathways during brain metastasis in lung adenocarcinoma: Gene expression and immunohistochemical analysis.
    Koh YW; Han JH; Haam S; Lee HW
    Pathol Res Pract; 2024 Aug; 260():155375. PubMed ID: 38878665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
    Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S
    Eur J Cancer; 2020 Jun; 132():24-34. PubMed ID: 32325417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.
    Yang M; Sun Y; Sun J; Wang Z; Zhou Y; Yao G; Gu Y; Zhang H; Zhao H
    Cancer Med; 2018 Apr; 7(4):1081-1092. PubMed ID: 29522283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma.
    Wang Z; Wang Y; Chang M; Wang Y; Liu P; Wu J; Wang G; Tang X; Hui X; Liu P; Guo X; Xing B; Wang Y; Han Z; Ma W
    Neuro Oncol; 2023 Jul; 25(7):1262-1274. PubMed ID: 36656750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
    Zhang L; Zhang Z; Yu Z
    J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immune-related gene expression signature predicts brain metastasis in lung adenocarcinoma patients after surgery: gene expression profile and immunohistochemical analyses.
    Koh YW; Han JH; Haam S; Lee HW
    Transl Lung Cancer Res; 2021 Feb; 10(2):802-814. PubMed ID: 33718023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases.
    Zhou Y; Shi X; Chen H; Mao B; Song X; Gao L; Zhang J; Yang Y; Zhang H; Wang G; Zhuang W
    Biomed Res Int; 2021; 2021():5557649. PubMed ID: 34337026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis.
    Yu Q; Wang Y; Yi G; Yang W; Chen K; Tan X; Zhang X; Xu Z; Yang Z; Peng Y
    Immunology; 2023 Feb; 168(2):320-330. PubMed ID: 36151890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based Model for Predicting the Risk of Brain Metastasis in Patients with Resected Lung Adenocarcinoma carrying the EGFR Mutation.
    Deng Q; Wang F; Song L; Chen L; Huang Y; Guo Z; Yang H
    Int J Med Sci; 2024; 21(4):765-774. PubMed ID: 38464823
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
    Xiao G; Li L; Tanzhu G; Liu Z; Gao X; Wan X; Xiao D; Chen L; Xia X; Zhou R
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.
    Shih DJH; Nayyar N; Bihun I; Dagogo-Jack I; Gill CM; Aquilanti E; Bertalan M; Kaplan A; D'Andrea MR; Chukwueke U; Ippen FM; Alvarez-Breckenridge C; Camarda ND; Lastrapes M; McCabe D; Kuter B; Kaufman B; Strickland MR; Martinez-Gutierrez JC; Nagabhushan D; De Sauvage M; White MD; Castro BA; Hoang K; Kaneb A; Batchelor ED; Paek SH; Park SH; Martinez-Lage M; Berghoff AS; Merrill P; Gerstner ER; Batchelor TT; Frosch MP; Frazier RP; Borger DR; Iafrate AJ; Johnson BE; Santagata S; Preusser M; Cahill DP; Carter SL; Brastianos PK
    Nat Genet; 2020 Apr; 52(4):371-377. PubMed ID: 32203465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma.
    Feng W; He Z; Shi L; Zhu Z; Ma H
    Biochem Genet; 2023 Oct; 61(5):1937-1966. PubMed ID: 36892747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Lung Adenocarcinoma and Brain Metastasis through Integrated Single-Cell Transcriptomics.
    Souza VGP; Telkar N; Lam WL; Reis PP
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.